APA (7th ed.) Citation

R, Y., T, Y., S, H., M, S., M, M., Y, H., . . . T, T. (2026). Optimal vancomycin AUC24/MIC ratio for predicting clinical outcomes in patients with glycopeptide-susceptible Enterococcus faecium bacteremia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. https://doi.org/10.1007/s10096-026-05473-w

Chicago Style (17th ed.) Citation

R, Yamaguchi, et al. "Optimal Vancomycin AUC24/MIC Ratio for Predicting Clinical Outcomes in Patients with Glycopeptide-susceptible Enterococcus Faecium Bacteremia." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 2026. https://doi.org/10.1007/s10096-026-05473-w.

MLA (9th ed.) Citation

R, Yamaguchi, et al. "Optimal Vancomycin AUC24/MIC Ratio for Predicting Clinical Outcomes in Patients with Glycopeptide-susceptible Enterococcus Faecium Bacteremia." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2026, https://doi.org/10.1007/s10096-026-05473-w.